News (179)

Biophytis: Phase 3 protocol unveiled in sarcopenia CF
Biophytis S A : presented the potential of RuvembriTM in the treatment of Duchenne Muscular Dystrophy - Form 6-K PU
Biophytis S A : and the University of Liège explore the potential of Sarconeos (BIO101) in the treatment of viral respiratory failure - Form 6-K PU
Biophytis S A : appoints Yann Meunier and Bernard Lévy to its Scientific Advisory Board - Form 6-K PU
BIOPHYTIS AND INNOVATION SOLUTIONS PHARMA SIGN A PARTNERSHIP AGREEMENT TO ACCELERATE MARKET ACCESS FOR SARCONEOS IN BRAZIL AQ
Biophytis S A : announces the launch of a rights issue with maintenance of shareholders’ preferential subscription rights to continue the execution of its strategic roadmap - Form 6-K PU
Biophytis S A : Interim Financial Report issued by the registrant on September 27, 2023 - Form 6-K PU
BIOPHYTIS AND SKYEPHARMA SIGN A PARTNERSHIP AGREEMENT FOR THE PRODUCTION OF SARCONEOS AQ
Biophytis S.A. Announces Executive Changes CI
Biophytis S A : receives a positive opinion for its SARA-31 phase 3 study in sarcopenia in Europe - Form 6-K PU
Biophytis S A : Press Release PU
BIOPHYTIS AND SEQENS SIGN A PARTNERSHIP TO PRODUCE SARCONEOS AQ
Biophytis applies for authorization for Sara-31 study CF
Biophytis S A : Press Release dated April 18, 2023 - Form 6-K PU
Biophytis S A : Results of the Combined General Meeting on April 17, 2023 PU
Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program EQ
Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference EQ
Biophytis S A : Press Release dated February 28, 2023 - Form 6-K PU
Biophytis announces the signature of a master service agreement with Intsel Chimos, a pharmaceutical company that will operate Sarconeos (BIO101) in France for the treatment of severe forms of COVID-1 EQ
Biophytis initiates the regulatory process for an early access authorization in France from the French National Authority for Health (HAS) for the treatment with Sarconeos (BIO101) of severe forms of EQ
: Biophytis To Host A Combined General Shareholder’s Meeting On March 30, 2023 EQ
Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19 EQ
Biophytis reports positive post-hoc analysis of the phase 2-3 COVA clinical study strongly supporting therapeutic potential of Sarconeos (BIO101) in COVID-19 EQ
Biophytis S A : Press Release dated October 31, 2022 - Form 6-K PU
Biophytis publishes its key financial figures as at 30 June 2022, announces a restatement of the financial statements published as of December 31st, 2021 and provides an update on the oper EQ
Biophytis participates in H.C. Wainwright 24th Annual Global Investment Conference EQ
Biophytis announces very promising top line results of its phase 2-3 COVA clinical study in COVID-19-related respiratory failure EQ
Biophytis S A : to update on the development of Sarconeos (BIO101) in Covid-19 at the 4th Annual Longevity Therapeutics Summit - Form 6-K PU
Biophytis SA to Update on the Development of Sarconeos in Covid-19 at 4th Annual Longevity Therapeutics Summit CI
Biophytis S A : presents the development of Sarconeos (BIO101) in Phase 3 for the treatment of Sarcopenia at the 15th SCWD International Congress - Form 6-K PU
Biophytis presents the development of Sarconeos (BIO101) in Phase 3 for the treatment of Sarcopenia at the 15th SCWD International Congress EQ
Biophytis: Results of the Combined General Meeting on June 21, 2022 All ordinary and extraordinary resolutions presented by the company have been adopted EQ
Biophytis S A : presents preclinical efficacy data for Sarconeos (BIO101) in Spinal Muscular Atrophy (SMA), a rare neuromuscular disease - Form 6-K PU
Biophytis presents preclinical efficacy data for Sarconeos (BIO101) in Spinal Muscular Atrophy (SMA), a rare neuromuscular disease EQ
Biophytis: Biophytis announces its participation at the BIO International Convention in San Diego from the 13th to the 16th of June EQ
Biophytis S A : €23.9M of available cash on December 31 2021 and new financing instruments for a total of €42M allowing financial visibility beyond mid 2023 - Form 6-K PU
Biophytis provides updates on Sarconeos (BIO101) clinical development EQ
Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives EQ
Biophytis S A : appoints Philippe Rousseau as Chief Financial Officer - Form 6-K PU
Biophytis appoints Philippe Rousseau as Chief Financial Officer EQ
Biophytis S A : received approval from ANVISA (Brazil) to give access to Sarconeos (BIO101) to hospitalized COVID-19 patients through an Expanded Access Program - Form 6-K PU
Biophytis received approval from ANVISA (Brazil) to give access to Sarconeos (BIO101) to hospitalized COVID-19 patients through an Expanded Access Program EQ
Biophytis S A : to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3 - Form 6-K PU
Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3 EQ
Biophytis S A : obtains a new 10M€ loan structure with Kreos Capital - Form 6-K PU
1234NextSee all

Insiders

Picture Stanislas Veillet
Stanislas Veillet

Stanislas Veillet is the founder.
He founded Biophytis SA in 2006 and currently holds the title of Chairman, President & Chief Executive Officer.
He is also currently the Chairman of Biophytis, Inc. and an Independent Director at Drone Volt SA. In the past, he worked as a Research Director at Danone SA, Pharmacia SAS, and Cargill France SAS.
He obtained a doctorate degree from AgroParisTech.


Picture Stanislas de Gramont
Stanislas de Gramont

Currently, Stanislas de Gramont holds the position of Chief Operating Officer for SEB SA. He is also on the board of Zhejiang Supor Co., Ltd. In his past career he held the position of Chief Executive Officer at Suntory Beverage & Food Europe Ltd. He received an undergraduate degree from ESSEC Business School.


Picture Eloïse Catherine Brigitte Veillet
Eloïse Catherine Brigitte Veillet

Eloïse Catherine Brigitte Veillet worked as an Analyst at Société Générale SA (UK) from 2008 to 2012.
She then worked as a Senior Analyst at Marble Bar Asset Management LLP from 2012 to 2014.
She also worked as an Analyst at SG Securities (Paris) SAS and as a Senior Consumer Analyst at DSAM Partners LLP.






Picture François Veillet
François Veillet

François Veillet was the Chairman of Technologies innovatrices d’imagerie, Inc.


Picture Ryan Veillet
Ryan Veillet

Ryan Veillet currently works as the President of Foundation Farms Corp.



Picture Jean Pierre Veillet
Jean Pierre Veillet

Jean Pierre Veillet founded Jean-Pierre Veillet Siteworks, Inc. in 1994.





Picture Stanislas Rouyer
Stanislas Rouyer

Stanislas Rouyer worked as an Associate Managing Director at Moody's Investors Service, Inc. from 1992 to 2022.


Picture Stanislas Vilgrain
Stanislas Vilgrain

Stanislas Vilgrain is currently the Chairman at Cuisine Solutions Europe SAS and a Director at Les Fromentiers de France SA. He was previously the Chief Executive Officer & Director at Cuisine Solutions, Inc. from 1993 to 2007.
Prior to that, he was the President-Culinary Division at Vie de France Corp.
from 1987 to 1991.





Picture Vanessa Stanislas
Vanessa Stanislas

Vanessa Stanislas has worked as a trustee for The Papworth Trust since 2017.


Picture Stanislas Choiseau
Stanislas Choiseau

Stanislas Choiseau has worked as Chairman & CEO at Groupe ATGT SA since 2011.
He is also currently the Chairman of ATGT Geometre-Expert SC and Director at Bureau d'Etudes et de Recherches Pour l'Industrie Moderne BE since 2013.






Picture Stanislas d'Audiffret
Stanislas d'Audiffret

Stanislas d'Audiffret worked as a Senior Director-Debt Advisory at bfinance UK Ltd.
and as a Principal at HSBC Bank Plc and Natixis SA. He obtained an undergraduate degree from ESSEC Business School in 2001.





Picture Stanislas Coppin
Stanislas Coppin

Stanislas Coppin has founded two companies, Gust Vision, Inc. in 2019 where he holds the title of Chief Executive Officer, and Unique Entertainment Experience SAS in 2018 where he also holds the title of Chief Executive Officer.
Mr. Coppin is also the founder of Mindie, Inc.



Picture Stanislas Guy Marie Ancel
Stanislas Guy Marie Ancel

Stanislas Guy Marie Ancel is currently a Director at MES Environmental Ltd., Hanford Waste Services Ltd., CNIM Azerbaïdjan Ltd., CNIM Asia Pacific Ltd., CNIM US Corp, and Lab Us Corp.
He was previously the Chief Executive Officer-Environment & Energy at CNIM Group SA, a Director at Le Lab SA, a Co-Managing Director at LAB GmbH, and a Director at Suncnim SAS.
Ancel received his undergraduate degree from Ecole Centrale Lyon in 1998.



Picture Stanislas Ronteix
Stanislas Ronteix

Stanislas Ronteix is currently the Deputy Chief Executive Officer at Marie Brizard Wine & Spirits SA. Previously, he held positions such as Chairman-Supervisory Board at Vilniaus Degtine AB, Senior Brand Manager at Rémy Cointreau SA from 1999 to 2003, Manager-International Marketing at Remy Martin SA from 2004 to 2007, and General Manager-Marketing at Bisquit Cognacs from 2010 to 2014.











Picture Stanislas Lavorel
Stanislas Lavorel

Stanislas Lavorel is the founder of Lavorel Medicare SA, established in 2012.
He is currently the Chairman of LvL Medical Paris et Nord SAS, Chairman-Management Board of Lavorel Groupe SA, Chairman of Chateau Des Ravatys SAS, and Director of LVL Maintenance et Logistique, LVL Home Service SA, LVL Medical Corse SA, Potinière SASU, Medivalys SA, Murs du Luxe SARL, and Supergab SARL.
His former positions include Director & Chief Executive Officer of LVL Médical Centre Est, Chief Executive Officer of JCL Finances SASU, Chairman of LVL Medical Sud-Ouest SAS, and Chief Operating Officer of LVL Médical Groupe SA from 1997 to 2010.


Picture Stanislas Laurent
Stanislas Laurent

Stanislas Laurent is currently the Chairman & Co-Chief Executive Officer at Hofmann SL and a Partner at Highland Capital Partners (UK) Management Ltd.
He previously served as the President & Chief Executive Officer at PhotoBox SAS, PhotoBox Ltd., and PhotoBox Holdco Ltd.
He was also an Independent Non-Executive Director at Pets At Home Group Plc.
Additionally, he was a Member-Supervisory Board at 11 88 0 Solutions AG from 2005 to 2011 and a Principal at Qxl Plc.
He briefly served as the Chief Operating Officer at Aol Europe in 2006.
Mr. Laurent holds an MBA degree from Harvard University.









Picture Stanislas Guerini
Stanislas Guerini

Stanislas Guerini currently works at Government of France, as Minister of Transformation & Public Service.


Picture Stanislas Kervyn
Stanislas Kervyn

Stanislas Kervyn is currently the Head of Compliance at NB Renaissance Partners since 2019.
Prior to this, he worked as the Chief Compliance Officer at Edmond de Rothschild Asset Management (Luxembourg) SA from 2008 to 2018.
He completed his undergraduate degree from Université Catholique de Louvain in 1990 and obtained an MBA from Cornell University Graduate School in 1991.





Picture Stanislas Gaillard
Stanislas Gaillard

Stanislas Gaillard - Partner Stanislas Gaillard joined Equistone in 1998.
Prior to this, he gained experience at Arthur Andersen where he dealt with companies in the industry, food and distribution sectors.
Stanislas has worked on a number of transactions including the spin-off of Médi-Partenaires, a leading French private hospital operator focused on medicine, surgery and obstetrics, the buyout of Martek Power a leading manufacturer of power conversion products for high technological industries and the buyout of Unither, the world-leading manufacturer of sterile pharmaceutical unit doses using Blow-Fill-Seal technology (BFS).
He is currently a member of the Supervisory Boards of Dugas, GSCM Groupe and Vulcain Ingénierie.
In addition to his investment and portfolio responsibilities, Stanislas also co-ordinates LBO NET, which is an association of buyout professionals (lawyers, accountants, private equity houses, mezzanine and senior debt lenders) that monitors the French buyout market.
Stanislas is a business school graduate with specialisation in corporate finance.
He also holds a degree in accounting (DESCF).


Picture Stanislas Michael Yassukovich
Stanislas Michael Yassukovich

Stanislas Michael Yassukovich currently works at Folio Corporate Finance Ltd., as Chairman.
Mr. Yassukovich also formerly worked at Telewest Communications Plc, as Deputy Chairman from 1999 to 2003, Merrill Lynch International, as Chairman from 1985 to 1991, Prometheus Energy Co., as Non-Executive Chairman, Manek Investment Management Ltd., as Chairman, London Stock Exchange Group plc, as Deputy Chairman from 1986 to 1989, Bristol & West Plc, as Vice Chairman from 1991 to 1999, Henderson EuroTrust Plc, as Chairman, EASDAQ NV, as Chairman from 1997 to 2000, ABC International Bank Plc, as Deputy Chairman, Cayzer Continuation PCC Ltd., as Chairman, and Securities Association of China, as Chairman from 1987 to 1991.











Picture Stanislas Bouchard
Stanislas Bouchard

Stanislas Bouchard currently works at Cristalco SAS, as Chief Executive Officer, Cristalco, as Chief Executive Officer from 1998, Eurosugar SAS, as Commercial Director from 2011, and SA Gardel, as Director from 2016.


Picture Stanislas Jean Rotman
Stanislas Jean Rotman

Dr. Stanislas J.
Rotman is a Founding Partner & Chief Executive Officer at Nevastar Finance Ltd.
He worked as an Investment Professional in the Investment Management Division of Goldman Sachs in New York, Zürich and London.
Dr. Rotman received his Chartered Financial Analyst (CFA) designation and holds an MBA in Finance from Cornell University (New York).
He is a Member of the CFA Institute and the CFA Society of the UK.
He is also a Doctor of Medicine and practiced surgery.


Picture Stanislas Piot
Stanislas Piot

Stanislas Piot served as the Chief Financial Officer & Head-Investor Relations at Stentys SA and as the Chief Financial Officer at QIAGEN Marseille SA. He also served as the Chief Financial Officer at Balyo SA from 2017 to 2019.
Piot received an undergraduate degree from Université Paris II Panthéon Assas.




Picture Stanislas M. Evva
Stanislas M. Evva

Stanislas M.
Evva
is the founder and current Chairman of Watchdog System SAS, which is founded in 2014.









Picture Stanislas Martin
Stanislas Martin

Stanislas Martin has held director positions at E D F Trading Ltd.
and EDF Trading North America LLC.






Picture Stanislas Augem
Stanislas Augem

Stanislas Augem served as an Independent Director at Nexity SA from 2014 to 2016.


Picture Stanislas Bressange
Stanislas Bressange

Stanislas Bressange has worked as a Director at Jean & Dominique Ensarguet since 2006 and currently holds the position of Chief Technology Officer at Vaudoise Assurances Holding SA since 2021.




Picture Stanislas Archambault
Stanislas Archambault

Stanislas Archambault is currently working as the Executive Director-Operational & Digital Marketing at Interparfums since 2005.
He previously worked as the Managing Director-Luxury Brands at Inter Parfums, Inc. Mr. Archambault completed his undergraduate degree at Instituts d'Études Avancées.










No results for this search